Menu
At Sapala, we stand as India’s leading CDMO specializing in nucleic acid chemistry, fortified by over 100 years of combined leadership experience in oligonucleotide and phosphoramidite synthesis. Our recent acquisition by Suven Pharma empowers us to leverage over three decades of CDMO expertise from the Suven Pharma and Cohance Lifesciences’ legacy, ensuring unparalleled service and innovation.
Heterocyclic compounds are the unsung heroes of our everyday world. With a simple structural tweak—adding a heteroatom—they become vital ingredients in pharmaceuticals, agrochemicals, and veterinary products. But their reach goes beyond, serving as antioxidants, corrosion inhibitors, and key components in dyes and other organic compounds. Nature, too, relies on them, with antibiotics like penicillin, cephalosporin and alkaloids like vinblastine, morphine, reserpine are built on these structures. Remarkably, nearly 60% of small-molecule drugs contain a nitrogen heterocycle. Sapala Organics excels in crafting these essential moieties, seamlessly contributing to industries we depend on daily.
Our team’s extensive experience in oligonucleotide and phosphoramidite synthesis allows us to deliver high-quality nucleic acids tailored for diverse research and therapeutic applications. We utilize cutting-edge methodologies to achieve optimal purity and yield.
We prioritize collaboration with clients to develop and optimize processes that ensure efficiency and scalability. Our industry experience equips us to effectively address challenges, ensuring timely delivery and compliance with regulatory standards.
Our analytical team employs state-of-the-art techniques for thorough characterization and quality control. We conduct comprehensive stability studies and validation, providing you with confidence in the integrity of our products.
Our knowledgeable regulatory team guides you through the complexities of compliance, ensuring adherence to both local and international regulations throughout the project lifecycle.
Our knowledgeable regulatory team guides you through the complexities of compliance, ensuring adherence to both local and international regulations throughout the project lifecycle.
Photochemistry leverages photons, often referred to as the “green reagent,” for chemical transformations. As photons are absorbed without leaving any residue, they promote reactions with excellent atom economy under mild conditions. This approach enables the generation of reactive intermediates, such as radicals and ions, while often providing a more efficient pathway than traditional thermal methods. Sapala Organics applies photochemistry to achieve high-yield results with sustainable processes.
With over 30 years of combined CDMO experience from Suven Pharma and Cohance, we bring best practices and proven strategies to our clients.
Our operations span 13 manufacturing sites, including 8 USFDA/EDQM accredited facilities, and boast over 2650 KL of reactor capacity, ensuring scalability and reliability.
We value strong relationships and work closely with our clients to achieve their goals.
Our streamlined processes enable us to meet deadlines without sacrificing quality.
At Sapala, we are dedicated to advancing your research and development endeavors through our specialized CDMO services. Whether you are a startup or a mammoth entity, our team is committed to supporting you at every stage.